Google France drug makers to form joint venture company: focus on diabetes treatment-Google, diabetes-IT information

IT news , September 12, Google's subsidiary, Verily the life sciences, as well as France drugmaker Sanofi today jointly announced that they will set up a joint venture company, focusing on providing products, equipment and services for people with diabetes.

Google and Sanofi said cooperation can give full play to each other's strengths and experience, Google could offer Sanofi micro electronics, analysis, software development, technical support, while Sanofi could provide a wealth of clinical data and experience, which is committed to bringing innovative treatments to diabetes.

Newly-established joint venture will be known as Onduo, was founded at the beginning of the new company will focus on the treatment of type 2 diabetes, in the current 400 million diabetes patients, diabetes accounted for 90% of the type, if you do not get effective control and treatment, and the number will continue to grow in the coming years.

Google and Sanofi did not disclose financial details of the joint venture Onduo, who claimed to have injected $ 248 million to the new company, approximately 50% shares of actual control, Sanofi and Google's cooperation had begun as early as last year.

谷歌与法国制药商组建合资公司：专注糖尿病治疗 - 谷歌,糖尿病 - IT资讯

IT资讯9月12日消息，谷歌旗下生命科学子公司Verily以及法国制药商Sanofi今天联合宣布，两者将成立一家合资公司，专注为糖尿病人提供产品、设备和服务。

谷歌和Sanofi表示，合作可以充分发挥双方的优势和经验，谷歌可以向Sanofi提供微型电子、分析、软件开发方面的技术支持，而Sanofi则可以提供丰富的临床实验数据和经验，两者将致力于为糖尿病患者带来创新性的治疗方法。

新成立的合资公司将定名为Onduo，新公司成立之初将专注于2型糖尿病的治疗，在目前全球4亿糖尿病患者中，该类型糖尿病患者就占了90%，如果不得到有效的控制和治疗，未来几年该数字还会继续增长。

谷歌和Sanofi并未透露合资公司Onduo的财务细节，后者称已经向新公司注资2.48亿美元，实际控制约50%的股份，Sanofi与谷歌的合作早在去年就已经开始。